| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-10 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
3e-05 |